INMD
InMode Ltd. NASDAQ Listed Aug 8, 2019$13.40
+0.30%
vs $13.36
Mkt Cap $877.0M
52w Low $12.76
16.6% of range
52w High $16.62
50d MA $13.93
200d MA $14.38
P/E (TTM)
9.4x
EV/EBITDA
2.9x
P/B
1.3x
Debt/Equity
0.0x
ROE
29.0%
P/FCF
10.4x
RSI (14)
29.10
ATR (14)
$0.20
Beta
2.12
50d MA
$13.93
200d MA
$14.38
Avg Volume
888.4K
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Tavor Building · Yokne'am, L3 2069206 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 0.30 | 0.25 | -16.1% | 13.59 | +0.0% | +2.4% | +0.3% | -1.4% | +0.4% | +1.5% | — |
| Feb 10, 2026 | AMC | 0.42 | 0.46 | +10.5% | 14.62 | +0.9% | -2.6% | +0.4% | +0.0% | +1.3% | -0.1% | — |
| Nov 5, 2025 | AMC | 0.35 | 0.38 | +8.3% | 14.53 | -1.6% | -0.6% | +0.1% | +1.0% | -0.6% | +0.7% | — |
| Jul 30, 2025 | AMC | 0.43 | 0.47 | +9.3% | 13.90 | -0.6% | -1.7% | +0.6% | +2.4% | +0.4% | -1.1% | — |
| Apr 28, 2025 | AMC | 0.33 | 0.31 | -6.1% | 14.26 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% | — |
| Feb 4, 2025 | AMC | 0.50 | 0.42 | -16.0% | 17.50 | +0.7% | +2.6% | +1.6% | -1.2% | +2.8% | +0.2% | — |
| Oct 30, 2024 | AMC | 0.63 | 0.70 | +11.1% | 17.87 | +0.1% | -4.4% | +1.1% | +0.7% | +3.0% | +7.7% | — |
| Aug 1, 2024 | AMC | 0.38 | 0.34 | -10.5% | 16.57 | -3.1% | +3.6% | -3.9% | +2.6% | -2.2% | +1.4% | — |
| May 2, 2024 | AMC | 0.41 | 0.32 | -22.0% | 17.36 | +2.1% | +1.6% | +5.7% | -0.8% | -1.1% | +0.3% | — |
| Feb 13, 2024 | AMC | 0.67 | 0.71 | +6.0% | 23.67 | +1.4% | -3.3% | +3.8% | -4.1% | -8.0% | -0.6% | — |
| Nov 2, 2023 | AMC | 0.64 | 0.61 | -4.7% | 21.76 | +0.3% | -1.3% | -4.7% | -3.9% | +1.6% | -1.5% | — |
| Jul 27, 2023 | AMC | 0.64 | 0.72 | +12.5% | 44.06 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% | — |
| May 2, 2023 | TNS | 0.47 | 0.52 | +10.6% | 33.83 | +1.2% | -0.4% | -4.3% | +4.4% | +3.8% | -0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.48 | $14.31 | -1.2% | -1.2% | +1.7% | -1.4% | +0.5% | -0.4% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $14.53 | $14.30 | -1.6% | -0.6% | +0.1% | +1.0% | -0.6% | +0.7% |
| Oct 10 | Needham | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | +0.2% | +0.9% | -1.1% | -0.3% |
| Oct 10 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.89 | $16.00 | +0.7% | -3.9% | +0.2% | +0.9% | -1.1% | -0.3% |
| Jul 30 | Needham | Maintains | Hold → Hold | — | $14.31 | $14.02 | -2.0% | -2.9% | -1.7% | +0.6% | +2.4% | +0.4% |
| Jul 30 | Barclays | Maintains | Overweight → Overweight | — | $14.31 | $14.02 | -2.0% | -2.9% | -1.7% | +0.6% | +2.4% | +0.4% |
| Jul 11 | Canaccord Genuity | Maintains | Hold → Hold | — | $15.18 | $15.07 | -0.7% | -3.1% | +0.2% | -3.3% | +0.1% | -1.1% |
| Apr 30 | Barclays | Maintains | Overweight → Overweight | — | $14.42 | $14.23 | -1.3% | -2.2% | +4.3% | -0.9% | -2.2% | +0.4% |
| Apr 29 | Canaccord Genuity | Maintains | Hold → Hold | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 29 | BTIG | Downgrade | Buy → Neutral | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $14.26 | $14.21 | -0.4% | +1.1% | -2.2% | +4.3% | -0.9% | -2.2% |
| Apr 28 | Needham | Maintains | Hold → Hold | — | $16.22 | $14.33 | -11.7% | -12.1% | +1.1% | -2.2% | +4.3% | -0.9% |
| Apr 14 | Jefferies | Maintains | Hold → Hold | — | $14.88 | $15.10 | +1.5% | +1.3% | +2.2% | -3.2% | +0.1% | -0.8% |
| Apr 14 | Needham | Maintains | Hold → Hold | — | $14.88 | $15.10 | +1.5% | +1.3% | +2.2% | -3.2% | +0.1% | -0.8% |
| Apr 9 | Needham | Maintains | Hold → Hold | — | $14.48 | $14.50 | +0.1% | +6.8% | -8.8% | +5.5% | +1.3% | +2.2% |
| Feb 5 | Barclays | Maintains | Overweight → Overweight | — | $17.50 | $17.62 | +0.7% | +2.6% | +1.6% | -1.2% | +2.8% | +0.2% |
| Feb 4 | Needham | Maintains | Hold → Hold | — | $16.67 | $17.20 | +3.2% | +5.0% | +2.6% | +1.6% | -1.2% | +2.8% |
| Jan 9 | Barclays | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Oct 14 | Barclays | Maintains | Overweight → Overweight | — | $16.50 | $16.22 | -1.7% | +0.9% | +0.0% | +1.4% | +2.0% | +3.3% |
| Jul 23 | Jefferies | Downgrade | Buy → Hold | — | $17.75 | $17.01 | -4.2% | +0.5% | -0.8% | -0.6% | +1.6% | +0.7% |
| Jul 15 | Barclays | Maintains | Overweight → Overweight | — | $17.87 | $17.96 | +0.5% | -0.2% | +6.9% | -1.8% | -4.2% | -1.4% |
| Jul 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $16.82 | $16.98 | +1.0% | +6.2% | -0.2% | +6.9% | -1.8% | -4.2% |
| Apr 12 | Barclays | Maintains | Overweight → Overweight | — | $18.47 | $18.20 | -1.5% | -3.0% | -1.3% | -0.4% | -1.0% | -0.6% |
| Feb 15 | Barclays | Maintains | Overweight → Overweight | — | $22.90 | $23.26 | +1.6% | +3.8% | -4.1% | -8.0% | -0.6% | -0.7% |
| Feb 14 | UBS | Maintains | Neutral → Neutral | — | $23.67 | $24.00 | +1.4% | -3.3% | +3.8% | -4.1% | -8.0% | -0.6% |
| Jan 18 | Barclays | Maintains | Overweight → Overweight | — | $21.88 | $22.04 | +0.7% | +4.7% | -1.4% | +2.1% | -0.3% | -1.2% |
| Jan 4 | Barclays | Maintains | Overweight → Overweight | — | $21.00 | $20.96 | -0.2% | +0.0% | -0.2% | +2.0% | +3.3% | -0.6% |
| Dec 7 | Canaccord Genuity | Maintains | Hold → Hold | — | $21.26 | $21.31 | +0.2% | -2.4% | +4.8% | -0.9% | -3.0% | +5.4% |
| Nov 3 | UBS | Downgrade | Buy → Neutral | — | $21.76 | $21.83 | +0.3% | -1.3% | -4.7% | -3.9% | +1.6% | -1.5% |
| Oct 13 | Canaccord Genuity | Downgrade | Buy → Hold | — | $22.40 | $22.31 | -0.4% | -7.4% | +2.7% | -0.4% | -2.3% | -4.2% |
| Aug 1 | Barclays | Maintains | Overweight → Overweight | — | $42.91 | $42.81 | -0.2% | +2.2% | -1.0% | -0.9% | -0.7% | +0.6% |
| Jul 28 | Baird | Maintains | Outperform → Outperform | — | $44.06 | $44.73 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% |
| Jul 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $44.06 | $44.73 | +1.5% | -2.7% | +0.1% | +2.2% | -1.0% | -0.9% |
| May 4 | Barclays | Maintains | Overweight → Overweight | — | $33.71 | $33.70 | -0.0% | -4.3% | +4.4% | +3.8% | -0.7% | -0.7% |
| Feb 17 | Needham | Downgrade | Buy → Hold | — | $39.69 | $37.56 | -5.4% | -6.7% | -3.3% | +0.7% | -0.3% | -3.2% |
| Feb 15 | Barclays | Maintains | Overweight → Overweight | — | $37.57 | $37.20 | -1.0% | +10.3% | -4.2% | -6.7% | -3.3% | +0.7% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $33.35 | $33.04 | -0.9% | -0.3% | +3.3% | -1.1% | +7.0% | +2.6% |
| Jun 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $23.26 | $22.86 | -1.7% | -3.7% | +0.4% | +6.1% | -3.7% | +3.5% |
| May 3 | Needham | Maintains | Buy → Buy | — | $25.61 | $25.79 | +0.7% | +1.7% | +5.1% | -9.0% | -2.3% | -10.1% |
| Feb 11 | Needham | Maintains | Buy → Buy | — | $51.34 | $50.73 | -1.2% | -8.4% | -3.0% | +3.9% | -1.9% | -8.5% |
| Oct 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.51 | $87.00 | -0.6% | -5.3% | +7.4% | +6.4% | +3.3% | +0.0% |
| Oct 13 | Barclays | Maintains | Overweight → Overweight | — | $75.44 | $78.33 | +3.8% | +13.8% | -0.8% | -2.1% | +2.0% | -0.3% |
| Oct 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $75.44 | $78.33 | +3.8% | +13.8% | -0.8% | -2.1% | +2.0% | -0.3% |
| Oct 12 | Needham | Maintains | Buy → Buy | — | $69.45 | $77.00 | +10.9% | +8.6% | +13.8% | -0.8% | -2.1% | +2.0% |
| Sep 27 | Needham | Maintains | Buy → Buy | — | $88.24 | $89.86 | +1.8% | -3.2% | -12.8% | +7.0% | -0.1% | -1.1% |
| Jul 29 | Needham | Maintains | Buy → Buy | — | $55.37 | $55.35 | -0.0% | +4.8% | -2.0% | +1.0% | +0.3% | +0.6% |
| Jul 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $55.37 | $55.35 | -0.0% | +4.8% | -2.0% | +1.0% | +0.3% | +0.6% |
| Jul 13 | Barclays | Maintains | Overweight → Overweight | — | $54.10 | $54.29 | +0.4% | +0.5% | -3.2% | -2.6% | +3.2% | +0.3% |
| Jul 12 | Needham | Maintains | Buy → Buy | — | $48.07 | $50.39 | +4.8% | +12.5% | +0.5% | -3.2% | -2.6% | +3.2% |
| May 6 | Baird | Maintains | Outperform → Outperform | — | $40.60 | $40.28 | -0.8% | -7.2% | +2.3% | -5.9% | +1.8% | -4.4% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Acadian Asset Management Llc | 2,593,203 | $35M | — | Mar 2026 |
| 2 | Renaissance Technologies Llc | 2,586,218 | $35M | Added | Mar 2026 |
| 3 | Morgan Stanley | 1,918,000 | $28M | Added | Dec 2025 |
| 4 | Menora Mivtachim Holdings Ltd. | 2,040,000 | $28M | New | Mar 2026 |
| 5 | Steel Partners Holdings L.p. | 1,795,361 | $25M | Added | Mar 2026 |
| 6 | Millennium Management | 1,161,780 | $16M | Reduced | Mar 2026 |
| 7 | Systematic Financial Management Lp | 1,154,457 | $16M | Added | Mar 2026 |
| 8 | Janus Henderson Group Plc | 932,132 | $13M | New | Mar 2026 |
| 9 | Lind Value Ii Aps | 606,403 | $8M | Added | Mar 2026 |
| 10 | Jpmorgan Chase & Co | 443,967 | $6M | Reduced | Mar 2026 |
| 11 | Susquehanna International Group, Llp | 341,809 | $5M | Added | Mar 2026 |
| 12 | Woodline Partners Lp | 312,271 | $4M | New | Mar 2026 |
| 13 | Jane Street Group, Llc | 279,087 | $4M | Reduced | Dec 2025 |
| 14 | D.e. Shaw & Co | 288,208 | $4M | Reduced | Mar 2026 |
| 15 | Meros Investment Management, Lp | 226,065 | $3M | Reduced | Mar 2026 |
| 16 | Marshall Wace, Llp | 224,715 | $3M | Reduced | Mar 2026 |
| 17 | Quantedge Capital Pte Ltd | 204,300 | $3M | Reduced | Mar 2026 |
| 18 | Ubs Group Ag | 160,980 | $2M | Reduced | Mar 2026 |
| 19 | Ark Investment Management Llc | 157,726 | $2M | Added | Mar 2026 |
| 20 | Northern Trust Corp | 156,819 | $2M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$877.0M
Enterprise Value
$326.6M
P/E (TTM)
9.37x
Forward P/E
9.28x
PEG Ratio
-0.28x
P/B
1.27x
P/S
2.37x
P/FCF
10.40x
EV/EBITDA
2.94x
Shares Out
65.4M
Financials (TTM)
Revenue
$370.5M
Net Income
$93.8M
EBITDA
$111.0M
Free Cash Flow
$84.3M
Op Cash Flow
$85.3M
EPS Basic
$1.45
EPS Diluted
$1.43
EPS Forward
$1.44
Gross Margin
78.5%
Op Margin
23.1%
Net Margin
25.3%
Balance Sheet
Total Assets
$766.4M
Total Liab.
$83.2M
Total Equity
$683.2M
Cash
$555.3M
LT Debt
$5.0M
Book Value/Sh
$10.57
Debt/Equity
0.02x
Current Ratio
9.88
Quick Ratio
8.61
Returns & Growth
ROE
29.0%
ROA
25.8%
ROIC
10.4%
Rev Growth YoY
-6.2%
EPS Growth YoY
-36.7%
Price Returns
2W
-0.9%
1M
-3.7%
3M
+1.3%
6M
-2.2%
12M
-5.0%
Technicals
52W High
$16.62
52W Low
$12.76
50d MA
$13.93
200d MA
$14.38
RSI (14)
29.10
ATR (14)
$0.20
Beta
2.12
Avg Volume
888K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$16.00
High
$17.00
Low
$15.00
Median
$16.00
Data updated apr 25, 2026 3:41pm
· Source: financialmodelingprep.com